致幻剂治疗物质使用障碍的治疗潜力探索
本文探讨致幻剂(尤其裸盖菇素)治疗酒精、尼古丁、海洛因及可卡因等物质使用障碍的潜力,指出其可干扰适应不良神经回路、促进神经可塑性并促成心理洞察,临床试验显示裸盖菇素辅助治疗可显著减少物质使用并改善心理健康,但存在法律、安全及研究严谨性挑战。
要点
- 致幻剂可能通过干扰适应不良神经回路和促进神经可塑性来治疗物质使用障碍。
- 裸盖菇素辅助治疗在临床试验中显示减少物质使用并改善心理健康结局。
- 法律障碍、安全顾虑及需要更严谨研究是当前主要挑战。
核心结论
- 致幻剂特别是裸盖菇素在治疗物质使用障碍方面显示出治疗潜力,未来谨慎乐观。
研究设计与样本
- 本文为综述类文章,探讨致幻剂在物质使用障碍治疗中的新兴作用。
主要发现
- 临床试验表明裸盖菇素辅助治疗在多种物质使用障碍中显著减少物质使用并改善心理健康结局。
- 致幻剂能够干扰适应不良神经回路、促进神经可塑性并促成解决物质使用障碍根源的心理洞察。
临床怎么用
- 致幻剂辅助治疗可能成为物质使用障碍的创新干预方式,但需考虑法律和安全问题。
局限性
- 存在法律障碍、安全顾虑,且需要更严谨的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psychedelics, particularly psilocybin, have garnered significant attention as potential therapeutic tools for treating substance use disorders (SUDs), such as those related to alcohol, nicotine, heroin (an opioid), or cocaine. Traditional treatments often fall short, leading to high relapse rates and an urgent need for innovative approaches. This article explores the emerging role of psychedelics in SUDs therapy, highlighting their ability to disrupt maladaptive neural circuits, promote neuroplasticity, and facilitate profound psychological insights that address the root causes of SUDs. Clinical trials demonstrate promising results across various forms of SUDs, with psilocybin-assisted therapy showing significant reductions in substance use and improved mental health outcomes. Despite the potential, challenges such as legal barriers, safety concerns, and the need for more rigorous research remain. The future of psychedelics in SUDs treatment is cautiously optimistic, with the possibility of transforming the field of SUDs therapy and offering hope to millions of individuals struggling with SUDs.
引用
- Li Y, Li H, Wang H, et al. Exploring the therapeutic potential of psychedelics in treating substance use disorders. Mol Psychiatry. 2025. PMID: 40830580. doi:10.1038/s41380-025-03168-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。